Skip to main content

Advertisement

SpringerLink
Log in

Parvovirus B19 infection-related acute hepatitis after rituximab-containing regimen for treatment of diffuse large B-cell lymphoma

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

References

  1. Daum S, Ullrich R, Heise W et al (2003) Intestinal non-Hodgkin’s lymphoma: a multicenter prospective clinical study from the German study group on intestinal non-Hodgkin’s lymphoma. J Clin Oncol 21:2740–2746

    Article  PubMed  Google Scholar 

  2. Friedberg JW, Fisher RI (2008) Diffuse large B-cell lymphoma. Hematol Oncol Clin North Am 22:941–952

    Article  PubMed  Google Scholar 

  3. Aksoy S, Harputluoglu H, Kilickap S et al (2007) Rituximab-related viral infections in lymphoma patients. Leuk Lymphoma 48:1307–1312

    Article  PubMed  CAS  Google Scholar 

  4. Kuo SH, Lin LI, Chang CJ et al (2002) Increased risk of parvovirus B19 infection in young adult cancer patients receiving multiple courses of chemotherapy. J Clin Microbiol 40:3909–3912

    Article  PubMed  Google Scholar 

  5. Langnas AN, Markin RS, Cattral MS et al (1995) Parvovirus B19 as a possible causative agent of fulminant liver failure and associated aplastic anemia. Hepatology 22:1661–1665

    PubMed  CAS  Google Scholar 

  6. Karetnyi YV, Beck PR, Markin RS et al (1999) Human parvovirus B19 infection in acute fulminant liver failure. Arch Virol 144:1713–1724

    Article  PubMed  CAS  Google Scholar 

  7. Quemelo PR, Lima DM, da Fonseca BA et al (2007) Detection of parvovirus B19 infection in formalin-fixed and paraffin-embedded placenta and fetal tissues. Rev Inst Med Trop São Paulo 49:103–107

    Article  PubMed  Google Scholar 

  8. Hsu TC, Tsay GJ (2001) Human parvovirus B19 infection in patients with systemic lupus erythematosus. Rheumatol (Oxf) 40:152–157

    Article  CAS  Google Scholar 

  9. Wang C, Heim A, Schlaphoff V et al (2009) Intrahepatic long-term persistence of parvovirus B19 and its role in chronic viral hepatitis. J Med Virol 81:2079–2088

    Article  PubMed  CAS  Google Scholar 

  10. Hartmann JT, Meisinger I, Kröber SM et al (2006) Progressive bicytopenia due to persistent parvovirus B19 infection after immunochemotherapy with fludarabine/cyclophosphamide and rituximab for relapsed B cell lymphoma. Haematologica 91(12 Suppl):ECR49

    PubMed  Google Scholar 

  11. Hillingsø JG, Jensen IP, Tom-Petersen L (1998) Parvovirus B19 and acute hepatitis in adults. Lancet 351:955–956

    PubMed  Google Scholar 

  12. Yang SH, Kuo SH (2008) Reactivation of hepatitis B virus during rituximab treatment of a patient with follicular lymphoma. Ann Hematol 87:325–327

    Article  PubMed  Google Scholar 

  13. McLaughlin P, Grillo-Lo’pez A, Link BK et al (1998) Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program. J Clin Oncol 16:2825–2833

    PubMed  CAS  Google Scholar 

Download references

Acknowledgements

This study was supported by research grants 98-2314-B-002-087-MY3 from the National Science Council, Taiwan; DOH96-DT-B-111-001 from the Department of Health, Taiwan; and NCTRC201010, NTUH 98-S1130 from National Taiwan University Hospital, Taiwan.

Conflict of interest

No financial or other potential conflicts of interest

Author information

Authors and Affiliations

  1. Department of Oncology, National Taiwan University Hospital, Yun-Lin Branch, Yunlin, Taiwan

    Shih-Hung Yang & Sung-Hsin Kuo

  2. Department of Pathology, National Taiwan University Hospital, Yun-Lin Branch, Yunlin, Taiwan

    Long-Wei Lin

  3. Department of Internal Medicine, National Taiwan University Hospital, Yun-Lin Branch, Yunlin, Taiwan

    Yu-Jen Fang

  4. Department of Oncology, National Taiwan University Hospital and National Taiwan University College of Medicine, 7, Chung-Shan South Road, Taipei, Taiwan

    Shih-Hung Yang, Ann-Lii Cheng & Sung-Hsin Kuo

  5. Department of Internal Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan

    Ann-Lii Cheng & Sung-Hsin Kuo

  6. Cancer Research Center, National Taiwan University College of Medicine, Taipei, Taiwan

    Ann-Lii Cheng & Sung-Hsin Kuo

Authors
  1. Shih-Hung Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Long-Wei Lin
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yu-Jen Fang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ann-Lii Cheng
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Sung-Hsin Kuo
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sung-Hsin Kuo.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yang, SH., Lin, LW., Fang, YJ. et al. Parvovirus B19 infection-related acute hepatitis after rituximab-containing regimen for treatment of diffuse large B-cell lymphoma. Ann Hematol 91, 291–294 (2012). https://doi.org/10.1007/s00277-011-1238-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-011-1238-8

Keywords

Search

Navigation